Aequus Announces Approval of Third Revenue Generating ProductVANCOUVER, British Columbia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or ...

--Aequus Pharmaceuticals Inc., a specialty pharmaceutical company announced today that it has submitted New Medical Device License applications for two dry eye products in the Evolve ® range.

“Evolve Intensive Gel is a one-of-a-kind formulation in Canada, and is... Aequus Receives Approval for New ‘Evolve - Intensive Gel’ Lubricating Eye Drops in Canada | Nasdaq Skip to main content ...